When.com Web Search

  1. Ads

    related to: newest drugs for osteoporosis treatment

Search results

  1. Results From The WOW.Com Content Network
  2. Romosozumab - Wikipedia

    en.wikipedia.org/wiki/Romosozumab

    Romosozumab, sold under the brand name Evenity (/ ɪ ˈ v ɛ n ɪ t i / ih-VENN-ih-tee or with the pin-pen merger, / ɪ ˈ v ɪ n ɪ t i / ih-VINN-ih-tee), is a medication used to treat osteoporosis. [7] [8] It has been found to decrease the risk of fractures of the spine. [7] Common side effects include headache, joint pain, and injection site ...

  3. Does Medicare cover Forteo, and how much does it cost? - AOL

    www.aol.com/does-medicare-cover-forteo-much...

    Forteo (teriparatide) is a brand-name drug that doctors prescribe for some people with osteoporosis. It contains proteins that strengthen bones and stimulate new bone growth.

  4. First osteoporosis drug of its kind for more than a decade ...

    www.aol.com/first-osteoporosis-drug-kind-more...

    The drug is one of only two treatments that help to promote bone formation, and the first to reduce bone loss at the same time. First osteoporosis drug of its kind for more than a decade approved ...

  5. Prolia: Is it covered by Medicare?

    www.aol.com/prolia-covered-medicare-010000191.html

    Prolia (denosumab) is an injectable medication that helps treat osteoporosis. Osteoporosis is a condition that causes the bones to become thin and weak, leading to a higher risk of fractures and ...

  6. Teriparatide - Wikipedia

    en.wikipedia.org/wiki/Teriparatide

    Teriparatide is indicated for the treatment of postmenopausal women with osteoporosis; [13] for the increase of bone mass in men with primary or hypogonadal osteoporosis; [13] and treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy.

  7. Bazedoxifene - Wikipedia

    en.wikipedia.org/wiki/Bazedoxifene

    Bazedoxifene is used in the prevention of postmenopausal osteoporosis. [5] Osteoporosis represents a major public health concern, especially as the number of postmenopausal women continues to rise. As a result, the need for innovative treatments has become increasingly important.